Sustainability Management
Basic Stance on Sustainability (Established August 1, 2023)
Based on our Corporate Philosophy of contributing to society through high-quality, well-evidenced pharmaceutical products and serving society through our people, Kissei Pharmaceutical Co., Ltd. (“we,” “our”) strives to simultaneously achieve the enhancement of corporate value and creation of a sustainable society, with the aims of contributing to the health of people around the world and solving global environmental and social issues through its business activities.
● Through the creation of innovation, we contribute to the health of people around the world and to the advancement of medical care through the development and provision of innovative products (pharmaceuticals, foods).
● Recognizing that environmental issues are a shared challenge for all humanity, we engage voluntarily and proactively in global environmental conservation activities, including measures to address climate change.
● In addition to respecting the human rights of all people involved in our business activities, we work to create fulfilling workplaces where the diversity, character, and individuality of our employees are respected.
● We strengthen and enhance corporate governance and engage in corporate activities with highly ethical, transparent, and fair practices. In this way, we maintain good relationships with stakeholders and pursue the sustained enhancement of corporate value.
Supplementary Provisions
Established August 1, 2023
Value Creation Process
Kissei Pharmaceutical identifies material issues based on the external environment, as well as conditions and challenges specific to the Company, and promotes value creation strategies to resolve these issues. We create value by leveraging our management capital to conduct strategic business activities under Beyond 80, our medium-term management plan. We then reinvest this value back into our management capital in a cycle that will help realize our Vision for the Next 10 Years.
Sustainability Promotion System (Governance)
Kissei’s sustainability activities are mainly promoted by the Sustainability Promotion Committee. The committee, which is chaired by a director well-versed in sustainability-related issues, is integrated into the Company’s corporate governance system, along with the Risk Management Committee and the Compliance Committee, all of which work closely with the Board of Directors as advisory bodies.
Specifically, the Sustainability Promotion Committees formulates various policies for sustainability-related issues and promotes these policies in cooperation with related departments.
Risk Management
As part of its Risk Management Regulations, Kissei Pharmaceutical established the Basic Risk Management Policy and a risk management system. In addition, the Company has established the Risk Management Committee, which serves as an advisory body to the Board of Directors. Under the guidance of this committee, the Kissei Group has put a management system in place to prevent the occurrence of possible risks, and monitors the system's implementation. Other relevant advisory bodies to the Board of Directors include the Compliance Committee and the Sustainability Promotion Committee. The Compliance Committee implements the Group’s compliance program and works to ensure proper compliance is taking place.
Kissei has positioned sustainability-related risks as important management risks, and the risks identified by the Sustainability Promotion Committee are reviewed once a year for their impact on business activities. When risks have a relatively large impact on business activities, we prioritize them in terms of cost effectiveness and degree of urgency, then implement countermeasures. The Sustainability Promotion Committee will discuss and report on the management status of these risks to the Board of Directors and the Risk Management Committee to integrate and promote comprehensive Companywide risk management.
